Patents by Inventor Neil McInnes

Neil McInnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260035162
    Abstract: An embodiment concerns a container for tobacco articles, each tobacco article comprising a filter; the container comprising: an outer box; an inner liner inserted in the outer box and configured to receive tobacco articles, the inner liner defining an internal surface designed to be in contact with the tobacco articles and an external surface in contact with the outer box; wherein at least one surface of the inner liner is coated with an anti-staining coating comprising a first anti-staining layer comprising ethyl cellulose to prevent or minimize staining from oily chemical substances contained in the filters of the tobacco articles.
    Type: Application
    Filed: August 16, 2023
    Publication date: February 5, 2026
    Applicant: JT INTERNATIONAL SA
    Inventors: Oliver BAUMHOEFER, Yuta ONUMA, Roland MAIER, Neil MCINNES
  • Patent number: 5563051
    Abstract: A process for the production of hyaluronic acid by continuous fermentation of Streptococcus in a chemostat culture gives high yields of high molecular weight hyaluronic acid uncontaminated by toxic impurities. The process is advantageous in that it solves the problem of traditional batch cultures in which degradation enzymes can begin to break down the cell walls of Streptococcus releasing cells contents into the fermenter broth complicating the purification of high molecular hyaluronic acid.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: October 8, 1996
    Assignee: Fermentech Medical Limited
    Inventors: Derek C. Ellwood, Charles Gervase T. Evans, Geoffrey M. Dunn, Neil McInnes, Richard G. Yeo, Keith J. Smith
  • Patent number: 5411874
    Abstract: A process for the production of hyaluronic acid by continuous fermentation of Streptococcus equi in a chemostat culture gives high yields of high molecular weight hyaluronic acid uncontaminated by toxic impurities. The process is advantageous in that it solves the problem of traditional batch culture in which degradation enzymes can begin to break down the cell walls of Streptococcus releasing cell contents into the fermenter broth, leading to purification difficulties.
    Type: Grant
    Filed: July 6, 1993
    Date of Patent: May 2, 1995
    Assignee: Fermentech Medical Limited
    Inventors: Derek C. Ellwood, Charles G. T. Evans, Geoffrey M. Dunn, Neil McInnes, Richard G. Yeo, Keith J. Smith